The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Plasma Protein Therapeutics-Global Market Insights and Sales Trends 2025

Plasma Protein Therapeutics-Global Market Insights and Sales Trends 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1816166

No of Pages : 109

Ask Your Query
Synopsis
Plasma Protein Therapeutics is use blood products to treat disease.Human blood plasma is nature's raw material for dozens of life-saving treatments and medications. By extracting the active ingredients and disinfection, people get related preparations from blood plasma, which is called blood product.
The global Plasma Protein Therapeutics market size is expected to reach US$ 44730 million by 2029, growing at a CAGR of 6.8% from 2023 to 2029. The market is mainly driven by the significant applications of Plasma Protein Therapeutics in various end use industries. The expanding demands from the Hemophilia, PID and Others,, are propelling Plasma Protein Therapeutics market. Coagulation Factor, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Immune Globulin segment is estimated at % CAGR for the next seven-year period.
Shire (Baxalta), CSL and Grifolsare the leaders of the Plasma Protein Therapeutics industry, which take about 55% market share. China is the major region of the global market, which takes about 45% market share.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Plasma Protein Therapeutics, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Plasma Protein Therapeutics market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Plasma Protein Therapeutics market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Plasma Protein Therapeutics sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Plasma Protein Therapeutics covered in this report include Shire (Baxalta), CSL, Grifols, Octapharma, Kedrion, LFB Group, Biotest, BPL and RAAS, etc.
The global Plasma Protein Therapeutics market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Shire (Baxalta)
CSL
Grifols
Octapharma
Kedrion
LFB Group
Biotest
BPL
RAAS
CBPO
Hualan Bio
Kamada
Global Plasma Protein Therapeutics market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Plasma Protein Therapeutics market, Segment by Type:
Coagulation Factor
Immune Globulin
Albumin
Others
Global Plasma Protein Therapeutics market, by Application
Hemophilia
PID
Others
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Plasma Protein Therapeutics manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Plasma Protein Therapeutics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index
1 Plasma Protein Therapeutics Market Overview
1.1 Plasma Protein Therapeutics Product Overview
1.2 Plasma Protein Therapeutics Market Segment by Type
1.2.1 Coagulation Factor
1.2.2 Immune Globulin
1.2.3 Albumin
1.2.4 Others
1.3 Global Plasma Protein Therapeutics Market Size by Type
1.3.1 Global Plasma Protein Therapeutics Market Size Overview by Type (2018-2029)
1.3.2 Global Plasma Protein Therapeutics Historic Market Size Review by Type (2018-2023)
1.3.3 Global Plasma Protein Therapeutics Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Plasma Protein Therapeutics Sales Breakdown by Type (2018-2023)
1.4.2 Europe Plasma Protein Therapeutics Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Plasma Protein Therapeutics Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Plasma Protein Therapeutics Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Plasma Protein Therapeutics Sales Breakdown by Type (2018-2023)
2 Global Plasma Protein Therapeutics Market Competition by Company
2.1 Global Top Players by Plasma Protein Therapeutics Sales (2018-2023)
2.2 Global Top Players by Plasma Protein Therapeutics Revenue (2018-2023)
2.3 Global Top Players by Plasma Protein Therapeutics Price (2018-2023)
2.4 Global Top Manufacturers Plasma Protein Therapeutics Manufacturing Base Distribution, Sales Area, Product Type
2.5 Plasma Protein Therapeutics Market Competitive Situation and Trends
2.5.1 Plasma Protein Therapeutics Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Plasma Protein Therapeutics Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Plasma Protein Therapeutics as of 2022)
2.7 Date of Key Manufacturers Enter into Plasma Protein Therapeutics Market
2.8 Key Manufacturers Plasma Protein Therapeutics Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Plasma Protein Therapeutics Status and Outlook by Region
3.1 Global Plasma Protein Therapeutics Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Plasma Protein Therapeutics Historic Market Size by Region
3.2.1 Global Plasma Protein Therapeutics Sales in Volume by Region (2018-2023)
3.2.2 Global Plasma Protein Therapeutics Sales in Value by Region (2018-2023)
3.2.3 Global Plasma Protein Therapeutics Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Plasma Protein Therapeutics Forecasted Market Size by Region
3.3.1 Global Plasma Protein Therapeutics Sales in Volume by Region (2024-2029)
3.3.2 Global Plasma Protein Therapeutics Sales in Value by Region (2024-2029)
3.3.3 Global Plasma Protein Therapeutics Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Plasma Protein Therapeutics by Application
4.1 Plasma Protein Therapeutics Market Segment by Application
4.1.1 Hemophilia
4.1.2 PID
4.1.3 Others
4.2 Global Plasma Protein Therapeutics Market Size by Application
4.2.1 Global Plasma Protein Therapeutics Market Size Overview by Application (2018-2029)
4.2.2 Global Plasma Protein Therapeutics Historic Market Size Review by Application (2018-2023)
4.2.3 Global Plasma Protein Therapeutics Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Plasma Protein Therapeutics Sales Breakdown by Application (2018-2023)
4.3.2 Europe Plasma Protein Therapeutics Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Plasma Protein Therapeutics Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Plasma Protein Therapeutics Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Plasma Protein Therapeutics Sales Breakdown by Application (2018-2023)
5 North America Plasma Protein Therapeutics by Country
5.1 North America Plasma Protein Therapeutics Historic Market Size by Country
5.1.1 North America Plasma Protein Therapeutics Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Plasma Protein Therapeutics Sales in Volume by Country (2018-2023)
5.1.3 North America Plasma Protein Therapeutics Sales in Value by Country (2018-2023)
5.2 North America Plasma Protein Therapeutics Forecasted Market Size by Country
5.2.1 North America Plasma Protein Therapeutics Sales in Volume by Country (2024-2029)
5.2.2 North America Plasma Protein Therapeutics Sales in Value by Country (2024-2029)
6 Europe Plasma Protein Therapeutics by Country
6.1 Europe Plasma Protein Therapeutics Historic Market Size by Country
6.1.1 Europe Plasma Protein Therapeutics Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Plasma Protein Therapeutics Sales in Volume by Country (2018-2023)
6.1.3 Europe Plasma Protein Therapeutics Sales in Value by Country (2018-2023)
6.2 Europe Plasma Protein Therapeutics Forecasted Market Size by Country
6.2.1 Europe Plasma Protein Therapeutics Sales in Volume by Country (2024-2029)
6.2.2 Europe Plasma Protein Therapeutics Sales in Value by Country (2024-2029)
7 Asia-Pacific Plasma Protein Therapeutics by Region
7.1 Asia-Pacific Plasma Protein Therapeutics Historic Market Size by Region
7.1.1 Asia-Pacific Plasma Protein Therapeutics Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Plasma Protein Therapeutics Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Plasma Protein Therapeutics Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Plasma Protein Therapeutics Forecasted Market Size by Region
7.2.1 Asia-Pacific Plasma Protein Therapeutics Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Plasma Protein Therapeutics Sales in Value by Region (2024-2029)
8 Latin America Plasma Protein Therapeutics by Country
8.1 Latin America Plasma Protein Therapeutics Historic Market Size by Country
8.1.1 Latin America Plasma Protein Therapeutics Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Plasma Protein Therapeutics Sales in Volume by Country (2018-2023)
8.1.3 Latin America Plasma Protein Therapeutics Sales in Value by Country (2018-2023)
8.2 Latin America Plasma Protein Therapeutics Forecasted Market Size by Country
8.2.1 Latin America Plasma Protein Therapeutics Sales in Volume by Country (2024-2029)
8.2.2 Latin America Plasma Protein Therapeutics Sales in Value by Country (2024-2029)
9 Middle East and Africa Plasma Protein Therapeutics by Country
9.1 Middle East and Africa Plasma Protein Therapeutics Historic Market Size by Country
9.1.1 Middle East and Africa Plasma Protein Therapeutics Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Plasma Protein Therapeutics Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Plasma Protein Therapeutics Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Plasma Protein Therapeutics Forecasted Market Size by Country
9.2.1 Middle East and Africa Plasma Protein Therapeutics Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Plasma Protein Therapeutics Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Shire (Baxalta)
10.1.1 Shire (Baxalta) Company Information
10.1.2 Shire (Baxalta) Introduction and Business Overview
10.1.3 Shire (Baxalta) Plasma Protein Therapeutics Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Shire (Baxalta) Plasma Protein Therapeutics Products Offered
10.1.5 Shire (Baxalta) Recent Development
10.2 CSL
10.2.1 CSL Company Information
10.2.2 CSL Introduction and Business Overview
10.2.3 CSL Plasma Protein Therapeutics Sales, Revenue and Gross Margin (2018-2023)
10.2.4 CSL Plasma Protein Therapeutics Products Offered
10.2.5 CSL Recent Development
10.3 Grifols
10.3.1 Grifols Company Information
10.3.2 Grifols Introduction and Business Overview
10.3.3 Grifols Plasma Protein Therapeutics Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Grifols Plasma Protein Therapeutics Products Offered
10.3.5 Grifols Recent Development
10.4 Octapharma
10.4.1 Octapharma Company Information
10.4.2 Octapharma Introduction and Business Overview
10.4.3 Octapharma Plasma Protein Therapeutics Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Octapharma Plasma Protein Therapeutics Products Offered
10.4.5 Octapharma Recent Development
10.5 Kedrion
10.5.1 Kedrion Company Information
10.5.2 Kedrion Introduction and Business Overview
10.5.3 Kedrion Plasma Protein Therapeutics Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Kedrion Plasma Protein Therapeutics Products Offered
10.5.5 Kedrion Recent Development
10.6 LFB Group
10.6.1 LFB Group Company Information
10.6.2 LFB Group Introduction and Business Overview
10.6.3 LFB Group Plasma Protein Therapeutics Sales, Revenue and Gross Margin (2018-2023)
10.6.4 LFB Group Plasma Protein Therapeutics Products Offered
10.6.5 LFB Group Recent Development
10.7 Biotest
10.7.1 Biotest Company Information
10.7.2 Biotest Introduction and Business Overview
10.7.3 Biotest Plasma Protein Therapeutics Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Biotest Plasma Protein Therapeutics Products Offered
10.7.5 Biotest Recent Development
10.8 BPL
10.8.1 BPL Company Information
10.8.2 BPL Introduction and Business Overview
10.8.3 BPL Plasma Protein Therapeutics Sales, Revenue and Gross Margin (2018-2023)
10.8.4 BPL Plasma Protein Therapeutics Products Offered
10.8.5 BPL Recent Development
10.9 RAAS
10.9.1 RAAS Company Information
10.9.2 RAAS Introduction and Business Overview
10.9.3 RAAS Plasma Protein Therapeutics Sales, Revenue and Gross Margin (2018-2023)
10.9.4 RAAS Plasma Protein Therapeutics Products Offered
10.9.5 RAAS Recent Development
10.10 CBPO
10.10.1 CBPO Company Information
10.10.2 CBPO Introduction and Business Overview
10.10.3 CBPO Plasma Protein Therapeutics Sales, Revenue and Gross Margin (2018-2023)
10.10.4 CBPO Plasma Protein Therapeutics Products Offered
10.10.5 CBPO Recent Development
10.11 Hualan Bio
10.11.1 Hualan Bio Company Information
10.11.2 Hualan Bio Introduction and Business Overview
10.11.3 Hualan Bio Plasma Protein Therapeutics Sales, Revenue and Gross Margin (2018-2023)
10.11.4 Hualan Bio Plasma Protein Therapeutics Products Offered
10.11.5 Hualan Bio Recent Development
10.12 Kamada
10.12.1 Kamada Company Information
10.12.2 Kamada Introduction and Business Overview
10.12.3 Kamada Plasma Protein Therapeutics Sales, Revenue and Gross Margin (2018-2023)
10.12.4 Kamada Plasma Protein Therapeutics Products Offered
10.12.5 Kamada Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Plasma Protein Therapeutics Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Plasma Protein Therapeutics Industrial Chain Analysis
11.4 Plasma Protein Therapeutics Market Dynamics
11.4.1 Plasma Protein Therapeutics Industry Trends
11.4.2 Plasma Protein Therapeutics Market Drivers
11.4.3 Plasma Protein Therapeutics Market Challenges
11.4.4 Plasma Protein Therapeutics Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Plasma Protein Therapeutics Distributors
12.3 Plasma Protein Therapeutics Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

Published By : QY Research

Why ‘The Market Reports’

In Business: Pre Sales Support: Post Sales Support: Turn Around Time: Clients Served: Clients Assisted: Client Types: Payment: Partners with: Number of reports: Custom Research: Report Availability: Report Delivery Format: Security:

Payments Accepted From

Connect with us at

Complete Secure Website

SiteLock